1. India Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
Centuple Global Ltd

Centuple Global Ltd

BBSE:CENTUPLE
37.00
INR
+1.14
(+3.18%)
2.26EPS
17.71P/E
218.73MMarket Cap
Centuple Global Ltd
BSE:CENTUPLE
(Bombay Stock Exchange)

Recent

price

37.00

P/E

ratio

17.71

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
INR
0.01
- -
- -
- -
- -
0.36
0.56
4.2
1.08
1.81
0.89
3.68
2.12
2.07
0.91
1,049.34
1,027.97
Revenue per Share
-0.31
-0.11
-0.1
-0.11
-5.62
-0.01
0.06
-0.3
-0.02
0.06
0.01
-0.07
-0.14
0.06
0.05
2.76
2.26
Basic EPS, GAAP
-0.09
-0.11
-0.09
-0.1
-0.15
-0.01
0.07
0.32
-0.05
0.21
0.94
-0.91
0.03
-0.03
0.35
-51.24
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
6.66
6.54
6.44
6.34
0.71
0.7
0.76
1.08
1.06
1.12
1.13
1.06
0.92
0.97
1.02
42.48
- -
Book Value per Share
6.66
6.54
6.44
6.34
0.71
0.7
0.76
1.08
1.06
1.12
1.13
1.06
0.92
0.97
1.02
42.48
- -
Tangible Book Value per Share
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
2
3
23
6
10
5
20
12
11
5
5,738
5,621
Sales/Revenue/Turnover
-4,019.25
- -
- -
- -
- -
-3.46
10.33
-1.53
-30.79
1.64
1.73
-1.14
-7.09
1.92
20.38
0.4
0.36
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
-2
-1
-1
-1
-31
- -
- -
-2
- -
- -
- -
- -
-1
- -
- -
15
12
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
31.93
30.96
- -
- -
- -
46.41
33.95
38.33
Effective Tax Rate (%)
-4,019.25
- -
- -
- -
- -
-3.48
11.13
-7.12
-1.93
3.2
1.16
-1.82
-6.77
2.67
5.08
0.26
0.22
Profit Margin (%)
5
5
4
4
1
1
1
6
6
6
6
6
4
5
6
232
- -
Working Capital
1
1
2
2
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
36
36
35
35
4
4
4
6
6
6
6
6
5
5
6
232
- -
Total Equity
- -
- -
- -
- -
- -
- -
8.5
- -
- -
4.8
0.76
- -
- -
- -
5.06
9.52
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
8.5
- -
- -
5.43
0.94
- -
- -
- -
4.66
9.88
- -
Return on Capital (%)
-4.53
-1.72
-1.5
-1.68
-159.46
-1.75
8.5
-32.41
-1.95
5.29
0.91
-6.09
-14.5
5.83
4.66
12.67
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
67
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
5
5
5
Market Capitalization
- -
- -
219

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
3,429
- -
Cash, Cash Equivalents & STI
- -
1
- -
Accounts Receivable, Net
- -
3,377
- -
Inventories
- -
11
- -
Total Current Liabilities
- -
3,197
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
67
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
410.74%
810.51%
4,061.2%
Free Cash Flow
-1,688.59%
-3,262.94%
-14,557.02%
Net Income, GAAP
331.03%
1,008.78%
5,833.86%
Sales/Revenue/Turnover
11,552.49%
22,975.17%
114,661.84%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
1
1
1
3
5
2026
117
1,086
1,741
2,794
5,738
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.05
-0.08
-0.03
0.12
0.05
2026
0.16
2.42
1.05
-0.87
2.76
2027
-0.34
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
Selcuk Ecza Deposu Ticaret ve Sanayi A.S. (BIST:SELEC)
McKesson Corporation (NYSE:MCK)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Business
Checkpoint Trends Limited, formerly known as Rubra Medicaments Ltd, is primarily engaged in the business of consultancy and trading. The company offers a range of consulting services across various sectors to cater to diverse client categories in India. Its consultancy services focus on management advisory and business process improvement. Additionally, the company is involved in trading activities. Headquartered in Hyderabad, India, Checkpoint Trends Limited was founded in 1971. In April 2022, the company underwent a significant corporate change by renaming itself from Rubra Medicaments Limited to Checkpoint Trends Limited, reflecting a strategic shift away from pharmaceutical manufacturing to consultancy and trading services. The company is listed on the BSE Limited. There have been no widely reported new product launches or major operational expansions in the last one to two years beyond this rebranding and business realignment, with the company continuing to focus on its core consultancy and trading segments within India.